from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0970/-

LFCtreatmentdescriptionclass of inhibitor

0.434

Amikacinug/mL Amikacintranslation

0.545

Cap5-10ug/mL Capreomycintranslation

-0.202

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.194

Rif0.2-5ug/mL Rifampicintranscription

-0.090

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.312

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.093

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.541

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.790

Clofazimine10-13 ug/mL Clofaziminerespiration

0.268

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.591

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.273

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.192

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.014

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.273

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.119

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.104

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.204

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.269

KCN5-20 ug/mL Potassium cyaniderespiration

-0.444

NaN30.2-2 mM Sodium aziderespiration

-0.651

Nigericin50 uM Nigericinrespiration

0.136

TRC10-150 ug/mL Triclosanrespiration

-0.509

TRZ10-25 ug/mL Thioridazinerespiration

0.971

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.314

menadione6-10 ug/mL Menadionerespiration

-1.317

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.487

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.269

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.638

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.521

NRP_1Non-replicating persistence stage 1dosRassociated

0.021

Amp0.2mg/mL AmpicillincellWall

0.255

Cephalexin20-100 ug/mL CephalexincellWall

0.006

Cerulenin0.32-5 ug/mL CerulenincellWall

0.000

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.150

EMB10-20 ug/mL EthambutolcellWall

0.079

Eta12-40 ug/mL EthionamidecellWall

0.202

INH0.2-0.4 ug/mL IsoniazidcellWall

1.057

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.556

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.958

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

BZA0.12 mg/mL BenzamidearomaticAmides

-0.482

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.323

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.332

H2O24 mM hydrogen peroxideDNAdamaging

-0.117

Levo10 ug/mL LevofloxacinDNAdamaging

0.998

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.197

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.285

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.652

UVUV-irradiationDNAdamaging

1.896

ARP41-4 ug/mL Antitubercular compound ARP4?

0.448

Antimycin12.5-50 ug/mL Antimycin A?

-0.753

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.880

PA_110-50 ug/mL Antitubercular compound PA-1?

1.246

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.097

PA8240.2-2 ug/mL PA-824?

0.755

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.449

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.629

Verapamil50 uM Verapamil?

-0.650

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.027

methoxatin10-20 ug/mL Methoxatin?